A NEW IDEA ON BELLICUM PHARMACEUTICALS $BLCM
This post was published on ZYX Buy Change Alert. BLCM is a clinical stage biopharmaceutical company focused on discovering and developing novel cellular immunotherapies for various forms of cancer, including both hematological cancers and solid tumors, as well as orphan inherited blood disorders. It is an upcoming IPO This is a call to buy in the IPO at the IPO price. To be clear, this is not a call to buy the stock post IPO or in the open market when the stock starts trading. Consider contacting your broker and requesting up to 100% of the full core position size. Consider